Indole-3-carbinol |
Cisplatin |
Cervical cancer cells |
Downregulation of Bcl-2 expression (99) |
|
LNCaP prostate cancer cells |
Inhibition of Akt/NF-κB signaling (20) |
Tamoxifen |
MCF-7 breast cancer cells |
Downregulation of CDK6 expression (82) |
TRAIL |
LNCaP cells (TRAIL-resistant) |
Induction of death receptor (DR)4 and DR5 expression (88) |
Ultraviolet B |
Melanoma cells |
Downregulation of Bcl-2 expression (100) |
|
DIM |
Taxotere |
MDA-MB-231 breast cancer cells |
Inactivation of Akt/NF-κB signaling (45) |
Paclitaxel |
Her2/Neu breast cancer cells |
Downregulation of Bcl-2 expression and Her2/Neu activation (101) |